Diabetes Devices Market Size, Share & Growth Analysis By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By End-Use (Hospitals, Homecare, Diagnostic Centers), And Regional Forecast, 2022-2028

Report Summary

Eternity Insights has published a new study on Global Diabetes Devices Market focusing on key segments as By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By End-Use (Hospitals, Homecare, Diagnostic Centers), and by region. This deep dive research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Diabetes Devices Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Diabetes Devices Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Diabetes Devices Market Size, 2018-2028 (USD Million)

Global Diabetes Devices Market Segmentation:

Diabetes Devices Market, By Type

• BGM Devices
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
• Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Diabetes Devices Market, By Distribution Channel

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Diabetes Devices Market, By End-use

• Hospitals
• Homecare
• Diagnostic Centers

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Diabetes Devices market in terms of demand generation. The Diabetes Devices market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Diabetes Devices market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Diabetes Devices Market Taxonomy:

Global Diabetes Devices Market Competitive Landscape

The global Diabetes Devices market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• Medtronic plc
• Abbott Laboratories
• Hoffmann-La-Ltd.
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Ypsomed Holdings
• Companion Medical
• Sanofi
• Valeritas Holding Inc.
• Novo Nordisk
• Arkray, Inc.
• Other Players of Specific Interest can be added based on the requirement

Market Segmentation

Key Benefits to the stakeholders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Diabetes Devices Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Assessment by Type
   2.1 Insulin Delivery Devices Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
   2.2 Glucose Monitoring Devices Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
   2.3 Artificial Pancreas System Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
   2.4 Other Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
3 Asia Pacific Diabetes Devices Market Assessment by Type
    3.1 Asia Pacific Market Performance (Sales, Revenue)
    3.2 Key Players in Asia Pacific
4 North America Diabetes Devices Market Assessment by Type
    4.1 North America Market Performance (Sales, Revenue)
    4.2 Key Players in North America
5 Europe Diabetes Devices Market Assessment by Type
    4.1 Europe Market Performance (Sales, Revenue)
    4.2 Key Players in Europe
6 South America Diabetes Devices Market Assessment by Type
    4.1 South America Market Performance (Sales, Revenue)
    4.2 Key Players in South America
7 Middle Easr and Africa Diabetes Devices Market Assessment by Type
    4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
    4.2 Key Players in Middle Easr and Africa
8 World Diabetes Devices Market Assessment by Type
    8.1 Asia Pacific Diabetes Devices Market Assessment by Application (Consumption and Market Share)
    8.2 North America Diabetes Devices Market Assessment by Application (Consumption and Market Share)
    8.3 Europe Diabetes Devices Market Assessment by Application (Consumption and Market Share)
    8.4 South America Diabetes Devices Market Assessment by Application (Consumption and Market Share)
    8.5 Middle East and Africa Diabetes Devices Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
    9.1 Medtronic
        9.1.1 Medtronic Profiles
        9.1.2 Medtronic Product Portfolio
        9.1.3 Medtronic Diabetes Devices Business Performance
        9.1.4 Medtronic Diabetes Devices Business Development and Market Status
    9.2 Sanofi
        9.2.1 Sanofi Profiles
        9.2.2 Sanofi Product Portfolio
        9.2.3 Sanofi Diabetes Devices Business Performance
        9.2.4 Sanofi Diabetes Devices Business Development and Market Status
    9.3 Novo Nordisk
        9.3.1 Novo Nordisk Profiles
        9.3.2 Novo Nordisk Product Portfolio
        9.3.3 Novo Nordisk Diabetes Devices Business Performance
        9.3.4 Novo Nordisk Diabetes Devices Business Development and Market Status
    9.4 Eli Lilly and Company
        9.4.1 Eli Lilly and Company Profiles
        9.4.2 Eli Lilly and Company Product Portfolio
        9.4.3 Eli Lilly and Company Diabetes Devices Business Performance
        9.4.4 Eli Lilly and Company Diabetes Devices Business Development and Market Status
    9.5 Roche
        9.5.1 Roche Profiles
        9.5.2 Roche Product Portfolio
        9.5.3 Roche Diabetes Devices Business Performance
        9.5.4 Roche Diabetes Devices Business Development and Market Status
    9.6 Medtronic
        9.6.1 Medtronic Profiles
        9.6.2 Medtronic Product Portfolio
        9.6.3 Medtronic Diabetes Devices Business Performance
        9.6.4 Medtronic Diabetes Devices Business Development and Market Status
    9.7 Baxter
        9.7.1 Baxter Profiles
        9.7.2 Baxter Product Portfolio
        9.7.3 Baxter Diabetes Devices Business Performance
        9.7.4 Baxter Diabetes Devices Business Development and Market Status
    9.8 Arkray
        9.8.1 Arkray Profiles
        9.8.2 Arkray Product Portfolio
        9.8.3 Arkray Diabetes Devices Business Performance
        9.8.4 Arkray Diabetes Devices Business Development and Market Status
10 World Diabetes Devices Market Assessment by Players
    10.1 Global Diabetes Devices Sales (K Units) and Market Share by Players 2017-2020
    10.2 Global Diabetes Devices Revenue (M USD) and Market Share by Players 2017-2020
    10.3 Global Diabetes Devices Price (USD/Unit) of Players 2017-2020
    10.4 Global Diabetes Devices Gross Margin of Players 2017-2020
    10.5 Market Concentration
11 Regional Market Performance by Segment of Players
    11.1 North America
        11.1.1 North America Diabetes Devices Sales Assessment of Players 2017-2020
        11.1.2 North America Diabetes Devices Revenue Assessment of Players 2017-2020
        11.1.3 North America Diabetes Devices Price Assessment of Players 2017-2020
        11.1.4 North America Diabetes Devices Gross Margin Assessment of Players 2017-2020
        11.1.5 Market Concentration
    11.2 Europe
        11.2.1 Europe Diabetes Devices Sales Assessment of Players 2017-2020
        11.2.2 Europe Diabetes Devices Revenue Assessment of Players of Manufacturers 2017-2020
        11.2.3 Europe Diabetes Devices Price Assessment of Players 2017-2020
        11.2.4 Europe Diabetes Devices Gross Margin Assessment of Players 2017-2020
        11.2.5 Market Concentration
    11.3 Asia-Pacific Market Performance for Manufacturers
        11.3.1 Asia-Pacific Diabetes Devices Sales Assessment of Players 2017-2020
        11.3.2 Asia-Pacific Diabetes Devices Revenue Assessment of Players 2017-2020
        11.3.3 Asia-Pacific Diabetes Devices Price Assessment of Players 2017-2020
        11.3.4 Asia-Pacific Diabetes Devices Gross Margin Assessment of Players 2017-2020
        11.3.5 Market Concentration
    11.4 South America Market Performance for Players
        11.4.1 South America Diabetes Devices Sales Assessment of Players 2017-2020
        11.4.2 South America Diabetes Devices Revenue Assessment of Players 2017-2020
        11.4.3 South America Diabetes Devices Price Assessment of Players 2017-2020
        11.4.4 South America Diabetes Devices Gross Margin Assessment of Players 2017-2020
        11.4.5 Market Concentration
    11.5 Middle East and Africa  Market Performance for Players
        11.5.1 Middle East and Africa  Diabetes Devices Sales Assessment of Players 2017-2020
        11.5.2 Middle East and Africa  Diabetes Devices Revenue Assessment of Players 2017-2020
        11.5.3 Middle East and Africa  Diabetes Devices Price Assessment of Players 2017-2020
        11.5.4 Middle East and Africa  Diabetes Devices Gross Margin Assessment of Players 2017-2020
        11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
    12.1 Asia Pacific
        12.1.1 Asia Pacific Diabetes Devices Sales by Countries/Regions 2017-2020
        12.1.2 Asia Pacific Diabetes Devices Revenue by Countries/Regions 2017-2020
        12.1.3 Asia Pacific Diabetes Devices Average Price by Countries/Regions 2017-2020
    12.2 North America
        12.2.1 North America Diabetes Devices Sales by Countries/Regions 2017-2020
        12.2.2 North America Diabetes Devices Revenue by Countries/Regions 2017-2020
        12.2.3 North America Diabetes Devices Average Price by Countries/Regions 2017-2020
    12.3 Europe
        12.3.1 Europe Diabetes Devices Sales by Countries/Regions 2017-2020
        12.3.2 Europe Diabetes Devices Revenue by Countries/Regions 2017-2020
        12.3.3 Europe Diabetes Devices Average Price by Countries/Regions 2017-2020
    12.4 South America
        12.4.1 South America Diabetes Devices Sales by Countries/Regions 2017-2020
        12.4.2 South America Diabetes Devices Revenue by Countries/Regions 2017-2020
        12.4.3 South America Diabetes Devices Average Price by Countries/Regions 2017-2020
    12.5 Middle East and Africa
        12.5.1 Middle East and Africa Diabetes Devices Sales by Countries/Regions 2017-2020
        12.5.2 Middle East and Africa Diabetes Devices Revenue by Countries/Regions 2017-2020
        12.5.3 Middle East and Africa Diabetes Devices Average Price by Countries/Regions 2017-2020
13 Technology and Opportunity
     13.1 Technology
     13.2 Market Opportunity
14 World Diabetes Devices Sales & Revenue Forecast 2021-2027
     14.1 World Diabetes Devices Sales and Revenue Forecast by Regions 2021-2027
        14.1.1 World Diabetes DevicesSales and Market Share by Regions
        14.1.2 World Diabetes DevicesRevenue and Market Share by Regions
15 Asia Diabetes Devices Market Forecast 2021-2027
     15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
        15.1.1 Insulin Delivery Devices
        15.1.2 Glucose Monitoring Devices
        15.1.3 Artificial Pancreas System
        15.1.4 Other
     15.2 Consumption Forecast by Application, 2021-2027
16 North America Diabetes Devices Market Forecast 2021-2027
     16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
        16.1.1 Insulin Delivery Devices
        16.1.2 Glucose Monitoring Devices
        16.1.3 Artificial Pancreas System
        16.1.4 Other
     16.2 Consumption Forecast by Application, 2021-2027
17 Europe Diabetes Devices Market Forecast 2021-2027
     17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
        17.1.1 Insulin Delivery Devices
        17.1.2 Glucose Monitoring Devices
        17.1.3 Artificial Pancreas System
        17.1.4 Other
     17.2 Consumption Forecast by Application, 2021-2027
18 South America Diabetes Devices Market Forecast 2021-2027
     18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
        18.1.1 Insulin Delivery Devices
        18.1.2 Glucose Monitoring Devices
        18.1.3 Artificial Pancreas System
        18.1.4 Other
     18.2 Consumption Forecast by Application, 2021-2027
19 Middle East and Africa Diabetes Devices Market Forecast 2021-2027
     19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2027
        19.1.1 Insulin Delivery Devices
        19.1.2 Glucose Monitoring Devices
        19.1.3 Artificial Pancreas System
        19.1.4 Other
     19.2 Consumption Forecast by Application, 2021-2027
20 Price (USD/Unit) and Gross Profit Forecast
     20.1 Global Diabetes Devices Price (USD/Unit) Trend 2021-2027
     20.2 Global Diabetes Devices Gross Profit Trend 2021-2027
21 Conclusion